Orange Book product · Generic (ANDA)
PARICALCITOL
PARICALCITOL
At a glance
Mar 09, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 09, 2017
9 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
PARICALCITOL
Strength
0.002MG/ML (0.002MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 206699
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PARICALCITOL
- 2016PARICALCITOLBrand (NDA)
NDA 207174 · ACCORD HLTHCARE
- 2014PARICALCITOLBrand (NDA)
NDA 205917 · HIKMA PHARMS
- 2014PARICALCITOLBrand (NDA)
NDA 201657 · HOSPIRA
- 2005ZEMPLARBrand (NDA)
NDA 021606 · ABBVIE
- 2000ZEMPLARBrand (NDA)
NDA 020819 · ABBVIE
- 2018PARICALCITOLGeneric (ANDA)
ANDA 205982 · EUGIA PHARMA
- 2017PARICALCITOLGeneric (ANDA)
ANDA 203897 · RISING
- 2017PARICALCITOLGeneric (ANDA)
ANDA 207692 · EPIC PHARMA LLC
- 2016PARICALCITOLGeneric (ANDA)
ANDA 204948 · MARKSANS PHARMA
- 2016PARICALCITOLGeneric (ANDA)
ANDA 204910 · CAPLIN
- 2016PARICALCITOLGeneric (ANDA)
ANDA 206710 · LOTUS PHARM CO LTD
- 2016PARICALCITOLGeneric (ANDA)
ANDA 207672 · AUROBINDO PHARMA LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
